UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Choosing cryptocurrencies as a beginner can be daunting. This guide provides insights into the best investment options to start your journey.
23,437 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Your Social Security statement holds more than a number. It’s a map of your work history, future benefits, and hidden...
Four giants could join the exclusive $3 trillion club by 2027. This article breaks down the drivers, the risks, and h...
As Palantir hype cools, two AI-driven cash-flow engines emerge as steadier bets. This report explains why Alphabet an...
A claim of six primary wins is fueling talk of a pro-crypto mandate. This article breaks down what that signal could ...
Microsoft’sAI push fuels cloud and enterprise gains even as capital outlays rise and OpenAI losses widen. Analysts ma...
IBM rallied today on a blend of solid earnings, growing cloud demand, and quantum computing momentum backed by govern...
Two key on-chain signals—Coinbase Premium and Exchange Netflows—may lead Bitcoin moves as Warsh takes the helm and li...
Three leading space names moved higher in a risk-on trading session, with AST SpaceMobile, Rocket Lab and Planet Labs...
As rates stay elevated in 2026, lenders are weighing unusual signals beyond credit scores. This report outlines the w...
The idea of lenders relaxing standards to resemble pre-2008 days is making waves. This in-depth guide explains what t...
The SEC is poised to unveil an innovation exemption for tokenized stocks, signaling a major shift in crypto trading a...